Response to: Correspondence on ‘Cardiovascular toxicities associated with bispecific T-cell engager therapy’ by Noguchi et al 22 de April de 2024 by Sayed, A., Munir, M., Poliner, M., Sughra, S., Epperla, N., Addison, D.